Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
2017 · Nature Communications · 39 citations
https://doi.org/10.1038/s41467-017-01114-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
443
Citations
6
h-index
6
i10-index
Shimona Madalli is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Immune Response and Inflammation & Cell Adhesion Molecules Research & Neutrophil, Myeloperoxidase and Oxidative Mechanisms. The author has an h-index of 6, co-authored 12 publications.
https://doi.org/10.1038/s41467-017-01114-1
https://doi.org/10.1007/s00125-017-4491-0
https://doi.org/10.1186/s13293-015-0047-5
Click to start Chat